Bank of Montreal Can Has $12.35 Million Holdings in Solventum Co. (NYSE:SOLV)

Bank of Montreal Can boosted its holdings in shares of Solventum Co. (NYSE:SOLV) by 15.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 182,748 shares of the company’s stock after acquiring an additional 25,002 shares during the period. Bank of Montreal Can owned 0.11% of Solventum worth $12,348,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in SOLV. Deseret Mutual Benefit Administrators bought a new position in Solventum during the 2nd quarter worth about $25,000. Hollencrest Capital Management acquired a new position in shares of Solventum in the second quarter valued at approximately $25,000. Richard W. Paul & Associates LLC acquired a new stake in shares of Solventum during the second quarter worth $26,000. Family Firm Inc. acquired a new stake in Solventum in the 2nd quarter worth about $26,000. Finally, Copeland Capital Management LLC bought a new position in Solventum during the 3rd quarter worth $26,000.

Analyst Ratings Changes

Several research analysts have commented on the company. Piper Sandler boosted their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Wells Fargo & Company decreased their price objective on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research report on Friday, August 9th. BTIG Research began coverage on Solventum in a report on Thursday, September 5th. They set a “neutral” rating on the stock. Wolfe Research began coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. Finally, Stifel Nicolaus initiated coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $68.00.

Solventum Stock Performance

Shares of Solventum stock opened at $71.51 on Monday. The stock’s fifty day moving average price is $70.55 and its 200-day moving average price is $62.58. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.